CD200 overexpression in AML can directly suppress anti-tumor NK cell and memory T cell functions [48–49], and the suppression of pro-inflammatory cytokines by CD4+ Th1 cells and CD8+ memory T cell numbers in AML patients can be restored with anti-CD200 treatment [48–49]. This evidence concerns the gene CD200 and acute myeloid leukemia.